Hong Kong-based AI healthtech startup opens up resources to global drug firms for free

(February 17 18:21) Techinasia.com

Insilico Medicine says pharmaceutical firms can use its AI-created compounds that are designed to work on a key “target” of the 2019-nCoV.

You can find the original article here